Henry Chi Hang Fung, MD, FRCPE

Request an Appointment Online - Click Here New patients can request an appointment online or call

Fox Chase Cancer Center
333 Cottman Ave
Philadelphia, PA 19111-2497

Video: Henry Chi Hang Fung, MD, FRCPE

Henry Chi Hang Fung, MD, FRCPE

Patient Stories from Fox Chase Patients Dr. Fung's
Patient Stories

Henry Chi Hang Fung, MD, FRCPE


Vice Chair, 
Hematology Programs
Bone Marrow Transplant Program

Meet other members of the
Hematologic Oncology Treatment Team.
More information about the 
Bone Marrow Transplant Program.

Clinical Expertise:

Multiple Myeloma, lymphoma, Blood and Marrow Transplantation


FRCPE, awarded by Royal College of Physician Edinburgh, 01/2001;
MRCP (UK), awarded by Royal College of  Physicians, United Kingdom 10/1991

Medical Education

MBChB Medicine, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, 1987


Hematology/Oncology, Queen Mary Hospital, Hong Kong University, 1991-1992;
Internal Medicine, Queen Mary Hospital, Hong Kong University, 1988-1991


Fellow, Hematology/Oncology, Queen Mary Hospital, Hong Kong University, Hong Kong;
Clinical Fellow, Division of Hematology, Vancouver Hospital and Health, Science Center, British Columbia Cancer Control Agency, University of British Columbia, Canada, 1992-1994

Honors and Awards

The Leading Physicians of the World, Top Oncologist in Chicago, International
Association of Oncologist, 2013;
Innovation Award (Henry C Fung MD and Rush SCT Program) – Chicago Chapter, American College of Health Executives, 2013;
Excellence Award, Chicago Chapter, Lymphoma Research Foundation, 2008;
Who’s Who in Medicine and Healthcare, 2007 – present;
Fellow, Royal College of Physicians Edinburgh, United Kingdom, 2001

Professional Societies

American College of Physicians;
American Society of Hematology;
American Society of Clinical Oncology;
American Society of Blood and Marrow Transplantation;
Royal College of Physicians, Edinburgh, United Kingdom

Research Interests

Allogeneic Stem Cell Transplant using alternative donors; Treatment and Stem Cell Transplant for Multiple Myeloma, Lymphoma and Leukemias, Myelodysplasia, Myeloproliferative disease and Myelofibrosis.


  1. Syed A. Abutalib, Kieron Dunleavy & Henry C. Fung: Primary Mediastinal B Cell Lymphoma. In Clinical Oncology (In Press)
  2. Henry C Fung, Philip Pancari and Patricia Kropf. Primary Central Nervous System Lymphoma. In Clinical Manual of Blood & Marrow Hematopoietic Cell Transplantation. Edited by Dr. Syed A. Abutalib & Dr. Parameswaran Hari (In Press)
  3. Sequential single-agent obatoclax mesylate (GX15-070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma.: A Goy, M Berger, P Ford, T Feldman, A Mato, C Bejot and Henry C Fung - Leukemia & lymphoma, 2014/12
  4. Gastrointestinal Side Effects and Adequacy of Enteral Intake in Hematopoietic Stem Cell Transplant Patients: M Walrath, C Bacon, S Foley, HC Fung - Nutrition in Clinical Practice, 2014/9
  5. Anger, provider responses, and pain: Prospective analysis of stem cell transplant patients: JI Gerhart, V Sanchez Varela, JW Burns, SE Hobfoll, HC Fung; Health Psychology 34 (3), 197
  6. Posttraumatic stress symptoms predict impaired neutrophil recovery in stem cell transplant recipients: SE Hobfoll, JI Gerhart, AK Zalta, K Wells, J Maciejewski and Henry C Fung- Psycho‐Oncology, 2015
  7. Evaluating Neutropenia Recovery in Patients Receiving Filgrastim on Day+ 5 Versus Day+ 10 Post Autologous Hematopoietic Stem Cell Transplant: LM DiGrazia, M Janusek, K Schultz, L Geswein, HC Fung; Journal of Oncology Pharmacy Practice (in press)
  8. Peksa GD, Schultz K, Fung HC: Dosing Algorithm for Concomitant Administration of Sirolimus, Tacrolimus, and an Azole After Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Oncology Pharmacy Practice.  2014 June 17: pii:1078155214539625. [Epub ahead of print]
  9. Christopherson KW 2nd, Frank R, Jagan S, Paganessi LA, Rizman A, Gezer S, Gregory SA, Fung HC: CD26 Protease Inhibition Improves Functional Response of Un-fractionated Mobilized Peripheral Blood Mononuclear Cells to CXCL12/SDF-1. Exp Hematol 2012 Nov;40(11):945-52.doi:10.1016/j.exphem.2012.07.009. Epub 2012 Jul 27
  10. Tuncer HH, Gregory SA, Fung HC: High-Dose Chemotherapy with Autologous Stem Cell Rescue for Relapse after Allo-SCT in Multiple Myeloma: A Case Report. Bone Marrow Transplant Oct 2010
  11.  Krishnan A, Nademanee A, Fung HC, Raubitschek AA, Molina A, Yamauchi D, Rodriguez R, Spielberger RT, Falk P, Palmer JM, Forman SJ: Phase II trial of a Transplantation Regimen of Yttrium-90 Ibritumomab Tiuxetan and High-Dose Chemotherapy in Patients with Non-Hodgkin’s Lymphoma. Journal of clinical Oncology 2008 Jan 1;26(1):90-5. Epub 2007 Nov 19
  12. Fung HC, Stif P, Schriber J, Toor A, Smith E, Rodriguez T, Krishnan A, Molina A, Smith D, Ivers, Kogut N, Popplewell L, Rodriguez R, Somlo G, Forman SJ, Nademanee A:. Tandem Autologous Stem Cell Transplantation for Patients with Primary Refractory or Poor Risk Recurrent Hodgkin Lymphoma. Biol Blood Marrow Transplant 2007 May;13(5):594-600. Epub 2007 Mar 23
  13. Sahebi F, Spielberger R, Kogut NM, Fung HC, et al.:  Maintenance Thalidomide Following Single Cycle Autologous Peripheral Blood Stem Cell Transplant in Patients with Multiple Myeloma. Bone Marrow Transplantation 2006 May;37(9):825-9
  14. Henry C Fung MBchB, FRCPE, Sunita Nathan MD, John J Maciejewski MD, PhD: Induction Chemotherapy Before Autologous Stem Cell Transplantation for Patients with Symptomatic Plasma Cell Myeloma----does it matter? Clinical Pharmacology: Advances and Applications (2010)
  15. A.M. Jimenez, Henry C Fung and Kent Chistopherson II: Strategies for Improving Transplant Efficiency in the Context of Cellular Therapeutics.  Transfusion 2011 Nov; 51 Suppl 4: 125S-137S.  doi: 10.1111/j. 1537-2995.2001.03375.x.